Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 29, 2022 - The FDA approved Mylan’s Ermeza (levothyroxine) oral solution.
Return to publications